Yazar "Alp, Cemalettin" seçeneğine göre listele
Listeleniyor 1 - 4 / 4
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Determination of secondary metabolites of Cydonia oblonga (Quince) by LC-MS/MS method together with evaluation of its antioxidant and cholinergic potentials(ACG Publications, 2024) Dikici, Emrah; Altın, Sevgi; Alp, Cemalettin; Işık, Mesut; Köksal, Ekrem; Gülçin, İlhamiIn this study, quantification of secondary metabolites of Cydonia oblonga (Quince) leaves by LC-MS/MS and antioxidant, cholinergic and ?-Glycosidase activities were reported. LC-MS/MS analyses of the studied extract showed that the highest phenolic constituents of species were catechin (2024.9 ± 80.9 ?g/L), vanillic acid (1121.8 ± 39.3 ?g/L) and fumaric acid (486.7 ± 16.5 ?g/L). The ethanol extract of quince leaves inhibited the ?-glycosidase enzyme with an IC50: 0.6 ?g/mL value. In order to determine the anti-Alzheimer activity of the plant extract, inhibition studies were carried out on acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes. The IC50 values of the plant extract were found to be 1.3 ?g/mL for AChE and 1.5 ?g/mL for BChE. In addition, free radical scavenging and metal reduction tests were performed to determine the antioxidant activity of the plant and the results were compared with Trolox. It was understood that the antioxidant potential of the plant was lower than Trolox. The results from biological abilities, molecular docking of catechin hydrate as abundant phenolic compounds in quince leaves extract to be an inhibitor candidate for AChE, BChE and ?-glycosidase.Öğe Phenolic Content, Antioxidant Capacity, and Therapeutic Potential of Mango (Mangifera indica L.) Leaves(John Wiley and Sons Inc, 2025) Işık, Mesut; Dikici, Emrah; Altın, Sevgi; Alp, Cemalettin; Kırboğa, Kevser Kübra; Köksal, Ekrem; Beydemir, ŞükrüThe phenolic composition, antioxidant capacity, and enzyme inhibition activities of Mangifera indica L. leaf (MLs) ethanol extract were comprehensively evaluated to explore its therapeutic and industrial applications. Quantitative profiling of 21 phenolic compounds was performed using the LC–MS/MS method, with vanillic acid (1242.47 μg/L), gallic acid (283.58 μg/L), and quercetin (102.40 μg/L) identified as the most abundant constituents. Antioxidant activities were assessed through DPPH, ABTS, FRAP, and CUPRAC assays, revealing moderate radical scavenging (DPPH: 26.87% ± 2.25%, ABTS: 14.65% ± 1.83%) and metal reduction capacities (FRAP: 0.118 ± 0.07, CUPRAC: 0.172 ± 0.03). In addition, MLs extract demonstrated dose-dependent inhibitory effects on acetylcholinesterase (AChE, IC50: 18.73 μg/mL), butyrylcholinesterase (BChE, IC50: 8.56 μg/mL), and α-glucosidase (IC50: 10.83 μg/mL), highlighting its potential in the management of neurodegenerative diseases such as Alzheimer's and metabolic disorders including diabetes. The findings emphasize the bioactive potential of M. indica leaves, positioning them as a promising resource for sustainable valorization. By showcasing the applicability of this agricultural by-product, the study provides a foundation for innovations in the food, nutraceutical, and pharmaceutical sectors. Nevertheless, further in vivo and clinical investigations are essential to fully validate their safety and therapeutic efficacy.Öğe Sulfapyridine-like benzenesulfonamide derivatives as inhibitors of carbonic anhydrase isoenzymes I, II and VI(Taylor & Francis, 2012) Alp, Cemalettin; Özsoy, Şeyda; Alp, Nurdan Alcan; Erdem, Deryanur; Gültekin, Mehmet Serdar; Küfrevioğlu, Ömer İrfan; Şentürk, Murat; Supuran, Claudiu T.The inhibition of two human cytosolic carbonic anhydrase (hCA, EC 4.2.1.1) isozymes I, II and human serum isozyme VI, with a series of tosylited aromatic amine derivatives was investigated. The K-I ranges of compounds 1-14 and acetazolamide against hCA I ranged between 1.130 and- 448.2 mu M, against hCA II between 0.103 and- 14.3 mu M, and against hCA VI ranged between 0.340 and- 42.39 mu M. Tosylited aromatic amine derivatives are thus interesting hCA I, II and VI inhibitors, and might be used as leads for generating enzyme inhibitors eventually targeting other isoforms which have not been assayed yet for their interactions with such agents.Öğe Therapeutic potential of Laurus nobilis extract by experimental and computational approaches: phenolic content and bioactivities for antioxidant, antidiabetic, and anticholinergic properties(Frontiers Media SA, 2025) Altın, Sevgi; Işık, Mesut; Alp, Cemalettin; Dikici, Emrah; Köksal, Ekrem; Kırboğa, Kevser Kübra; Rudrapal, Mithun; Rakshit, Gourav; Beydemir, Şükrü; Khan, JohraLaurus nobilis (LN), has traditional medicinal uses, and this study investigates its therapeutic potential by focusing on its phenolic content and bioactivities such as antioxidant, antidiabetic, and anticholinergic properties. Phenolic compounds play key roles in reducing oxidative stress and modulating enzymatic activities, relevant to metabolic and neurodegenerative disorders. Methods: LN leaf extracts were prepared via ethanol maceration, followed by filtration and concentration. Phenolic content was analyzed using LC-MS/MS. Antioxidant activity was assessed through ferric thiocyanate, DPPH, ABTS, and FRAP assays. Enzyme inhibition assays targeted AChE, BChE, and α-GLY, with IC50 values from dose-response curves. In silico analyses were conducted using molecular docking techniques to predict the binding mechanisms of identified phenolic compounds with the active sites of target enzymes, evaluating binding affinities and interaction profiles. Results: Vanillic acid and catechin hydrate were the most abundant phenolics. LN extract showed strong lipid peroxidation inhibition (50.53%) compared to Trolox (28.33%) and α-tocopherol (37.79%). Moderate radical scavenging and metal reduction potentials were observed. IC50 values were 2.57 µg/L for AChE, 3.78 µg/L for BChE, and 4.65 µg/L for α-GLY, indicating notable bioactivity. In silico studies confirmed strong binding affinities of phenolics to target enzymes. Discussion: LN extracts demonstrated promising antioxidant, antidiabetic, and anticholinergic activities, attributed to high phenolic content. Enzyme inhibition results suggest potential in managing metabolic and neurodegenerative disorders. In silico findings support these bioactivities, highlighting LN’s therapeutic potential.
